Amir T. Fathi MD [slides]- IDH 1/2-Mutant AML Treatment Acute Myelogenous Leukemia 1 Min Read17 Amir T. Fathi MD Associate Professor of Medicine, Harvard Medical School Program Director, Center for Leukemia- Massachusetts General Hospital Join…
Amir Fathi, MD- Induction in patients without FLT3 mutations Acute Myelogenous Leukemia 1 Min Read9 Amir Fathi, MD Associate Professor of Medicine, Harvard Medical School Program Director, Center for Leukemia- Massachusetts General Hospital. Amir Fathi MD, an esteemed professional…
